CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-18 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +154,169 | 154,169 | ||
| 2016-08-18 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Unit | +24,979 | 24,979 | ||
| 2016-08-17 | LUCAS ROGER C Director | Sale | −100 | $113.70 | $11K | 3,415 |
| 2016-07-20 | LUCAS ROGER C Director | Sale | −100 | $111.03 | $11K | 3,615 |
| 2016-07-09 | Gould Kevin S SVP Clinical Controls | Shares withheld for taxes | −309 | $115.17 | $36K | 2,191 |
| 2016-07-01 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −277 | $112.24 | $31K | 1,946 |
| 2016-07-01 | Eansor Norman David SVP - Novus Biologicals | Shares withheld for taxes | −533 | $112.24 | $60K | 3,936 |
| 2016-06-15 | LUCAS ROGER C Director | Sale | −100 | $112.15 | $11K | 3,715 |
| 2016-05-18 | LUCAS ROGER C Director | Sale | −100 | $102.53 | $10K | 3,815 |
| 2016-05-09 | Dinarello Charles A Director | Sale | −5,000 | $101.91 | $510K | 6,559 |
| 2016-05-06 | LUCAS ROGER C Director | Sale | −500 | $100.24 | $50K | 3,915 |
| 2016-05-05 | Dinarello Charles A Director | Option exercise | +5,000 | $56.17 | $281K | 11,559 |
| 2016-05-05 | Dinarello Charles A Director | Option exercise · Stock Options (Right to Buy) | −5,000 | 0 | ||
| 2016-04-20 | LUCAS ROGER C Director | Sale | −100 | $92.40 | $9K | 4,315 |
| 2016-03-31 | Hippel James Chief Financial Officer | Option exercise | +1,666 | 6,100 | ||
| 2016-03-31 | Hippel James Chief Financial Officer | Shares withheld for taxes | −556 | $94.52 | $53K | 5,544 |
| 2016-03-31 | Hippel James Chief Financial Officer | Option exercise · Restricted Stock Units | −1,666 | 1,667 | ||
| 2016-03-16 | LUCAS ROGER C Director | Sale | −100 | $92.90 | $9K | 4,415 |
| 2016-02-05 | LUCAS ROGER C Director | Option exercise | +5,000 | $70.35 | $352K | 9,515 |
| 2016-02-05 | LUCAS ROGER C Director | Sale | −5,000 | $83.68 | $418K | 4,515 |
Page 63 of 64 · 1,274 trades